Full-Time

Senior Software Engineer

Cloud

Hyperfine

Hyperfine

51-200 employees

Portable bedside MRI system for hospitals

Compensation Overview

$143.5k - $165k/yr

+ Bonus + Equity Plans

No H1B Sponsorship

Branford, CT, USA

In Person

Category
Software Engineering (1)
Required Skills
Microsoft Azure
Python
JavaScript
React.js
Node.js
Postgres
Docker
TypeScript
AWS
Nginx
Flask
Google Cloud Platform
Requirements
  • Building modern cloud services on AWS, Google Cloud Platform, or Microsoft Azure.
  • Backend web development experience including best software engineering practices, efficient object-oriented software design, and building modern back-end systems using Python.
  • Building and developing APIs and RESTful web services using Node.js, Flask/Nginx, Docker, PostgreSQL, SQLAlchemy.
  • Frontend web development with JavaScript, TypeScript, and modern frameworks such as React.
  • Experience translating wireframes and requirements into web applications in collaboration with product and UI/UX designers.
  • Bachelor's degree in Computer Science or related field with 8+ years of work experience; or Master's Degree in Computer Science with 5+ years of work experience; or equivalent.
  • Prior experience working in a regulated environment (preferred).
  • Ability to participate in on-call rotation and maintain service uptime.
  • Top-notch written and oral communication skills in English.
  • Applicants must be authorized to work for any employer in the United States; we cannot sponsor visas now or in the future.
Responsibilities
  • Develop software systems and cloud applications focusing on maintenance, extensibility, integration, and security of data storage and retrieval.
  • Quickly learn new tooling, platforms, and frameworks when building and developing microservices and APIs.
  • Adopt new policies, technologies, and practices and evolve existing methodologies.
  • Implement comprehensive medical web application systems for multiple large-scale internal and external facing projects and document the design and specifications for internal and regulatory documentation.
  • Participate in the code review process.
  • Collaborate with software and cross-functional teams in design and technical reviews.
  • Define high-level architecture, design and implement software solutions, assume accountability for the deployment and release of contributed code, and support the post-release lifecycle of products.
  • Mentor and support other engineers on the cloud team in areas of expertise.
  • Maintain familiarity with compliance standards mandated within a regulated medical device environment.
  • Contribute code to medical device software for cloud connectivity, including over-the-air updates, telemetry, user management, medical Internet of Things, and Picture Archiving and Communication System relay.
Desired Qualifications
  • Experience with building and deploying medical device cloud connectivity software including OTA, Telemetry, User Management, Medical Internet of Things, and PACS relay is strongly preferred (not strictly required).
  • Experience with regulated medical device software development practices and compliance processes is preferred.
  • Experience with cloud security best practices and secure software development lifecycle for healthcare/medical device environments.

Hyperfine creates medical imaging tools for hospitals, focusing on the Swoop system, the first FDA-cleared portable ultra-low field MRI that can image a patient’s brain at the bedside. How it works: a compact, portable MRI device is brought to the patient in settings like intensive care units, performing brain scans without moving the patient to a radiology suite. The open, safe design allows family members to stay nearby during imaging. Differentiation: it is already FDA-cleared and designed for point-of-care use, enabling bedside decision-making, faster treatment decisions, quicker discharges, and more efficient use of hospital staff and resources at a lower cost compared to traditional MRI workflows. Revenue model: Hyperfine sells the Swoop system and related services to hospitals, clinics, and other healthcare facilities. Goal: improve patient care by bringing diagnostic imaging directly to patients, increasing access to timely brain imaging and streamlining clinical workflows.

Company Size

51-200

Company Stage

IPO

Headquarters

Guilford, Connecticut

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue surged 83% to $3.9M from next-gen Swoop sales.
  • NVIDIA March 2026 collaboration accelerates AI image reconstruction and scan times.
  • $3.7M Gates Foundation grant funds neonatal imaging in low-resource settings.

What critics are saying

  • GE Healthcare and Siemens launch competing ultra-low field MRIs within 12-24 months.
  • $40.8M cash lasts to late 2027 without profitability or new funding.
  • Horizon $40M loan's 10.75% interest and warrants dilute equity immediately.

What makes Hyperfine unique

  • Swoop system delivers first FDA-cleared portable ultra-low field MRI for bedside brain imaging.
  • Optive AI software upgrade cleared December 2025 enhances stroke detection via multi-direction DWI.
  • Open design allows family presence during ICU scans, unlike traditional high-field MRIs.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Hyperfine who can refer or advise you

Benefits

Remote Work Options

Hybrid Work Options

Wellness Program

Mental Health Support

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-2%

2 year growth

0%
The Associated Press
Apr 9th, 2026
Hyperfine wins CE and UKCA marks for next-gen Swoop MRI system and Optive AI software

Hyperfine has received CE marking and UK Conformity Assessment approval for its next-generation Swoop portable MRI system and latest Optive AI software, enabling commercialisation across Europe and the UK. The approvals mark a key milestone in the company's international growth strategy. The next-generation Swoop system, FDA-cleared in Q2 2025, delivers improved image quality and workflow for brain imaging. The updated Optive AI software includes multi-direction diffusion-weighted imaging capabilities, enhancing stroke detection similar to high-field MRI scanners. The technology is currently distributed across over a dozen European countries through Hyperfine's network. The company plans to begin commercialisation of the new system and software in Europe and the UK in early Q3 2026, ahead of internal expectations.

Yahoo Finance
Mar 19th, 2026
Hyperfine reports $5.3M Q4 revenue, up 128%, targets $21M in 2026 with 50%+ margins

Hyperfine Inc reported record fourth-quarter revenue of $5.3 million, up 128% year-over-year, driven by strong performance of its next-generation Swoop scanner. The medical imaging company sold 16 units in Q4, compared to nine units in the prior-year period. Gross margin expanded to 50.9%, up 1,530 basis points from Q4 2024, whilst net loss narrowed to $5.9 million from $10.4 million. Full-year 2025 revenue reached $13.6 million, up 5% from 2024. The company received FDA clearance for updated Optive AI software and gained approval for its first-generation Swoop system in India. Hyperfine reduced cash burn by 30% year-over-year to $5.7 million. For 2026, the company projects revenue of $20 million to $22 million, representing 55% growth at the midpoint, with gross margins of 50% to 55%.

Yahoo Finance
Mar 18th, 2026
Hyperfine reports $5M Q4 revenue as portable brain MRI gains traction in hospitals

Hyperfine reported fourth-quarter revenue exceeding $5 million, driven by accelerating adoption of its second-generation Swoop portable brain MRI system and Optive AI software. CEO Maria Sainz described the combination as a "market turning point" for portable brain MRI, highlighting diagnostic-quality imaging from ultra-low field magnets. The company has sold over a dozen next-generation systems since June 2025, focusing on critical care, emergency departments and neurology offices. The FDA cleared a software update in December 2025 featuring diffusion-weighted imaging for stroke workflows. Hyperfine cited external validation including published health economic data from Jefferson Abington Hospital showing cost savings across 143 scans. Yale School of Medicine's PRIME study evaluating AI-powered portable MRI in emergency departments completed enrollment ahead of schedule, with results expected later in 2026.

Stock Titan
Mar 18th, 2026
Hyperfine (NASDAQ: HYPR) adds $40M loan facility and over 1.0M stock warrants

Hyperfine arranged a $40M senior secured loan with Horizon, drawing $15M initially, at a minimum 10.75% rate and issuing over 1.0M stock warrants at $1.20 per share.

Business Wire
Nov 20th, 2025
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health

$3.7M grant supports expanded use of portable MRI to evaluate brain development and guide targeted health interventions in underserved communities.